Company Overview and News

17
PRESS DIGEST- British Business - Oct 19

20h reuters
Oct 19 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
RDS.B RDS.A BNPQY RDSB SFTBF BNPQF RDSA HCS HSB 0005 BNPZY RYDBF HSEA HSEB 9984 RYDAF HSBC SFTBY DIS HBCYF

64
Asia's technology bear isn't ready to hibernate

2018-10-17 businesstimes.com.sg
Until recently, US technology companies seemed immune to the escalating trade war with China. Their Asian peers, meanwhile, have collapsed.
FB TMUSP TMUS NFLX GOOG SFTBF WFM BABA S GOOGL 0700 AAPL 9984 BIDU SFTBY

10
Treebo and FabHotels initiate merger talks

2018-10-17 livemint
Mumbai: Budget hotel brands Treebo and FabHotels have initiated merger talks, as investor appetite to fund hotel startups is waning following the massive funding round by market leader Oyo Rooms, three people familiar with the matter said. Oyo, India’s largest and fastest-growing hotel chain, had secured $800 million from the SoftBank Vision Fund last month.
BABA RCKZF 9984 SFTBF SFTBY

2
SoftBank lines up $9 billion in loans for Vision Fund from banks: Bloomberg

2018-10-17 reuters - 1
(Reuters) - Banks, including underwriters of SoftBank Group’s (9984.T) initial public offering of its mobile unit, are finalizing terms for a $9 billion loan to its Vision Fund, Bloomberg reported on Wednesday, citing people familiar with the matter.
MZHOF NMR DB SMFG SFTBF SMFNF 8604 N33 8316 NRSCF 8411 9984 SFTBY MFG

1
SoftBank lines up $9 billion in loans for Vision Fund from banks: Report

2018-10-17 moneycontrol
Banks, including underwriters of SoftBank Group's initial public offering of its mobile unit, are finalising terms for a $9 billion loan to its Vision Fund, Bloomberg reported on Wednesday, citing people familiar with the matter.
MZHOF NMR DB SMFG SFTBF SMFNF 8604 N33 8316 NRSCF 8411 9984 SFTBY MFG

7
SoftBank 'anxiously' monitoring Saudi Arabia situation: executive

2018-10-17 channelnewsasia
Softbank Group Chief Operating Officer Marcelo Claure said it is "business at usual" at the companies backed by its nearly US$100 billion Vision Fund despite a tense situation with Saudi Arabia, which provided nearly half of the fund's capital.
AAPL 9984 SFTBF INTC QCOM SFTBY

22
Uber targets valuation of over $100 billion with much-anticipated IPO, sources say

2018-10-17 japantimes.co.jp
NEW YORK – Uber Technologies Inc. is eyeing a valuation above $100 billion for its much-anticipated share offering due in 2019, which would be the biggest-ever in the tech sector, sources familiar with the plan said Tuesday.
DGLD TM SFTBF CS GS GLSSP UGLD JEF MS GM SFTBY JBK DSLV VIIX GSC CSSLF VIIZ TFG TYT TOYOF GSJ CSGKF 7203 ZIV USLV 9984 TVIX GJS XIV

 
Tokyo stocks bounce back, thanks to bargain hunters

2018-10-16 japantimes.co.jp
The Nikkei 225 average rose 277.94 points, or 1.25 percent, to end at 22,549.24 after plunging 423.36 points Monday.
9984 SFTBF 8035 TOELF SFTBY TOELY

5
Amid Japan’s changing work-style landscape, office space provider WeWork grows at a dizzying pace

2018-10-16 japantimes.co.jp
The seven-story tower with a glass exterior near Tokyo’s trendy Omotesando district serves not just a co-working space with computers and free Wi-Fi. There is also a pantry, a bar counter and a spacious lounge where you can drink freshly roasted coffee and beer on tap free of charge. There is even a room for meditation or prayer.
KWHIF MARUF KWHIY SNE SFTBF 9984 7012 SNEJF 8630 SFTBY

 
Asia Markets: Asian markets rise, driven by oil-company gains

2018-10-16 marketwatch
A day after a broad selloff, Asian stock markets gained in early trading Tuesday, despite modest losses on Wall Street.
HYUO 9984 HYUP SFTBF SFTBY HYUD

10
SoftBank CEO, Saudi’s prince and a $22 billion test of values

2018-10-16 japantimes.co.jp
Masayoshi Son has already paid a price for his close ties to Saudi Arabia. It could soon go much higher.
BABA 9984 SFTBF SFTBY

52
Microsoft Stock Poised to Benefit From Grab Investment

2018-10-15 investorplace
On October 9, Microsoft (NASDAQ:MSFT) announced a partnership with Grab, the Singapore-based ride-hailing service which has supplanted Uber in Southeast Asia. The deal should boost Microsoft stock over the longer term.
IBM FB TM TYT GOOG SFTBF TOYOF BABA AMZN GOOGL 7203 MSFT 9984 SFTBY

18
Defensive stocks help S&P, Dow eke out gains, offset tech pressure

2018-10-15 reuters
(Reuters) - A drop in technology stocks on Monday kept pressure on Wall Street and led the Nasdaq lower, but the S&P 500 and Dow Jones Industrial Average eked out slim gains as defensive sectors rose, while traders also pointed to technical support.
FOX 9984 HRS SFTBF FOXA DIS SFTBY

 
Wall St drops as Apple leads tech lower, Saudi tensions flare up

2018-10-15 theedgemarkets
NEW YORK (Oct 15): US stocks fell on Monday, coming off their worst five-day drop in seven months last week, as Apple led technology stocks lower and tensions between Western powers and Saudi Arabia added to already frayed investor nerves ahead of earnings.
9984 HRS SFTBF SFTBY

 
Wall St. drops as Apple leads tech lower, Saudi tensions flare up

2018-10-15 reuters
(Reuters) - U.S. stocks fell on Monday, coming off their worst five-day drop in seven months last week, as Apple led technology stocks lower and tensions between Western powers and Saudi Arabia added to already frayed investor nerves ahead of earnings.
9984 HRS SFTBF SFTBY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to SFTBY / Softbank Group on message board site Silicon Investor.

Softbank Group Corp Softbank Group Corp Softbank Group Corp
CUSIP: 83404D109